Ian Hardy

Dr. Hardy is Vice President of Chemistry, Manufacturing & Controls (CMC) for Deerfield Discovery and Development. He is responsible for leading CMC development, manufacturing and supply chain activities for all therapeutic modalities for Deerfield’s academic translator companies and some early stage portfolio companies.

As an advisor to the Appello senior management team, he brings more than 25 years of industry experience leading CMC development activities from preclinical through commercialization and lifecycle management in both large pharma at GlaxoSmithKline, AstraZeneca and Merck, as well as emerging biopharmaceutical companies, most recently Lycera.

Dr. Hardy holds a Ph.D. degree in Pharmaceutics from the University of Nottingham and an M.B.A. from Warwick Business School.